Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0372 | 0 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0749 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0749 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0749 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0749 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.0749 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0749 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0749 | 1 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0749 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0664 | 0.7743 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0463 | 0.2407 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0372 | 0 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0749 | 1 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0749 | 1 | 0.5 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0664 | 0.7743 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0749 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0749 | 1 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0749 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0749 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0749 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0378 | 0.0151 | 0.0151 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0749 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0749 | 1 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0749 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0749 | 1 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0749 | 1 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0749 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0463 | 0.2407 | 0.2407 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0749 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.122 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.